Otolaryngologist, head and neck surgeon Francis T. Hall discusses the evaluation of thyroid nodules, which primarily aims to determine the likelihood of malignancy. He then reviews the treatment of thyroid nodules and thyroid cancer, including recent advances in management
Choosing a safe and effective anticoagulant is complicated when patient is obese
+Print Archive
Practice
Choosing a safe and effective anticoagulant is complicated when patient is obese
Wednesday 29 January 2020, 01:00 AM

Treatment failure is a concern when using direct-acting oral anticoagulants in patients with high body weight
PHARMACOTHERAPY
It is likely you will come across obese patients requiring anticoagulation. This article summarises international studies and guidelines, to help you determine whether a direct-acting oral anticoagulant or vitamin K antagonist is the best option.
Linda Bryant and Pauline McQuoid
Key points, Warfarin is the anticoagulant of choice for obese patients.
Direct-acting oral anticoagulants should be avoided in patients with high body weight (B
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.